latest news.

Cosette Pharmaceuticals Partners With Mark Cuban Cost Plus Drug Company to Make CLOMID® More Affordable

The First Fertility Drug to be Offered by Mark Cuban Cost Plus Drug Company


Together, everyone at Cosette contributes to a culture that fosters innovation, celebrates collaboration and recognizes excellence. We are perpetually pursuing the highest quality standards, the most efficient supply chain and innovating every day in everything we do.


Our highly experienced leadership team is busy writing the next, most ambitious chapter of our story. Building on a 100+ year heritage, their shared vision of innovation will leverage our expertise, efficiency, and infrastructure to create remarkable new opportunities.


While staying true to our proud therapeutic history of dermatology products, suppositories, and oral liquids, we’re busy expanding our offerings – through strategic partnerships and internal R&D. Our focus on innovation and supply reliability is the foundation of our rapidly diversifying portfolio.

we care.

Cosette is committed to understanding patients’ unique health journeys so we can anticipate their needs and help achieve their goals.



Cosette Pharmaceuticals Acquires Vyleesi® (Bremelanotide Injection) from Palatin Technologies Inc.

We are excited to announce that our women’s healthcare portfolio has expanded with the addition of…

Read More

Cosette Pharmaceuticals Appoints Ted Smolenski as Vice President of Portfolio & Business Development

Cosette Pharmaceuticals, Inc., a New Jersey-based specialty pharmaceutical company, today announced…

Read More